Combination drug strategies for biofilm... (2023 study) Skip to main content
Review Front Cell Infect Microbiol 2023

Combination drug strategies for biofilm eradication using synthetic and natural agents in KAPE pathogens

Bari A, Belalekar T, Poojary A, Rohra S, Front Cell Infect Microbiol, 2023

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The authors reviewed published work on drug combinations used against biofilm-forming bacteria that resist antibiotics.

What They Found

This review lists current combination therapies for Gram-negative and Gram-positive biofilm-forming pathogens and briefly compares how well the combinations work, and the abstract gives no numerical results. The abstract says combination drug therapies have shown potential to eradicate biofilm infections. It reports that inhaled fosfomycin with tobramycin has been effective against both Gram-negative and Gram-positive organisms. It also says natural or synthetic adjuvants show promising effects, and that EDTA, sodium dodecyl sulphate and chlorhexidine act by killing non-growing cells in the inner layer of the biofilm. The abstract states that low oxygen tension in the biofilm matrix disrupts fluoroquinolone activity, and that hyperbaric oxygen treatment can enhance antibiotic efficacy if well optimized.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This is a review, so it reports no new patient data, and the abstract gives no figures or comparisons that test how well the combinations work against each other.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Review
Category Infection
Source Pubmed
PubMed ID 37139491
Year Published 2023
Journal Front Cell Infect Microbiol
MeSH Terms Biofilms; Anti-Bacterial Agents; Bacteria; Tobramycin; Chlorhexidine

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 17, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology